Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2
I see Bloomberg was today badgering Dr Severin Schwan, the Roche chief executive, into providing a denial to my BioMarin story from a few weeks ago.
According to the Bloomberg story I read today, Dr Schwan said Roche was looking at small to medium-sized acquistions although he believes biotech valuations are "too high" even after the recent market correction.
But when the Bloomberg hack tried to elicit a denial or confirmation by asking spefically about Roche's interest in BioMarin Dr Schwan declined to comment.
I wonder why.....